Triple A Syndrome — Research Summary
Printed from RareWays (rareways.com.au) on 18 September 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Clinical and Electrodiagnostic Characterization of Pediatric Triple A Syndrome: A Cohort of 17 Patients.
Kipoğlu Osman et al. — Muscle & nerve (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42481394/
- 2.
Achalasia, alacrimia, and normal adrenal function in a toddler: GDP-mannose pyrophosphorylase A-congenital disorder of glycosylation mimicking Allgrove syndrome.
Koppula Prounika et al. — Clinical and experimental pediatrics (19 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42661487/
- 3.
Clinical features of hereditary adrenocortical unresponsiveness to adrenocorticotropin (HAUA) in Japan: from a nationwide questionnaire based survey.
Tanimoto Eri et al. — Endocrine journal (11 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42586722/
- 4.
ALLGROVE SYNDROME (TRIPLE A SYNDROME): A REVIEW
N. Sakthi Bharathi & G. Sarojini — Zenodo (CERN European Organization for Nuclear Research) (12 June 2026)
https://doi.org/10.5281/zenodo.20671653
- 5.
ALLGROVE SYNDROME (TRIPLE A SYNDROME): A REVIEW
N. Sakthi Bharathi & G. Sarojini — Zenodo (CERN European Organization for Nuclear Research) (12 June 2026)
https://doi.org/10.5281/zenodo.20671654
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Triple A Syndrome
Triple A syndrome, also called Allgrove syndrome, is a rare inherited condition caused by changes in the AAAS gene. It typically combines adrenal insufficiency, achalasia of the oesophagus and reduced tear production, and many people also develop nerve and autonomic problems over time. Management includes hormone replacement, treatment for swallowing difficulties, lubricating eye drops and neurological care.
Most Recent Research
INTRODUCTION/AIMS: Triple A syndrome is an autosomal recessive disorder characterized by alacrima, achalasia, and adrenal insufficiency. Neurological involvement is common, but its electrodiagnostic (EDX) patterns are varied. The resulting phenotype, often marked by spasticity, can lead to diagnostic confusion with other motor neuron disorders. We aimed to define the neurological and EDX spectrum in a pediatric cohort and clarify their diagnostic relevance. METHODS: This was a cross-sectional study of 17 pediatric patients with genetically confirmed triple A syndrome. All patients underwent neurological examinations by a pediatric neurologist. EDX data, including nerve conduction studies (NCS) and concentric needle electromyography (EMG) from 14 patients, were systematically analyzed for motor and sensory involvement. RESULTS: Neurological examinations revealed upper motor neuron (UMN) signs, including hyperreflexia, extensor plantar responses, lower limb hypertonia, and a spastic gait pattern, including toe walking and early heel rise. Some patients showed peripheral neuropathy signs, including pes cavus and distal muscle atrophy. EDX studies indicated a predominantly distal, axonal motor polyneuropathy with infrequent sensory involvement. Needle EMG demonstrated chronic neurogenic changes in distal muscles; however, active denervation, such as fibrillation potentials and fasciculation potentials, were observed in only one patient. DISCUSSION: The presence of spastic paraparesis and hyperreflexia may clinically resemble hereditary spastic paraplegia, while distal motor involvement may raise consideration of motor neuron disorders. The predominance of chronic neurogenic changes and the relative infrequency of active denervation on needle EMG are key diagnostic features that help differentiate Triple A syndrome from classical motor neuron diseases.
Common Questions
What is Triple A Syndrome?
Triple A syndrome, also called Allgrove syndrome, is a rare inherited condition caused by changes in the AAAS gene. It typically combines adrenal insufficiency, achalasia of the oesophagus and reduced tear production, and many people also develop nerve and autonomic problems over time. Management includes hormone replacement, treatment for swallowing difficulties, lubricating eye drops and neurological care.
How many clinical trials are available for Triple A Syndrome?
No clinical trials are currently indexed for Triple A Syndrome. This may change as new trials are registered. Check back regularly or visit ClinicalTrials.gov directly.
Where does the research data for Triple A Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Triple A Syndrome.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.